Vitiligo-like depigmentation following neoadjuvant chemotherapy combined with pembrolizumab in early triple-negative breast cancer: a case report
BackgroundTriple-negative breast cancer (TNBC) is a biologically aggressive subtype of breast cancer associated with an unfavourable prognosis. In recent years, the combination of immune checkpoint inhibitors with neoadjuvant chemotherapy has become a standard treatment strategy for selected patient...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2026-07-01
|
| Collection: | Frontiers in Oncology |
| Sujets: | |
| Accès en ligne: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1817257/full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|